Table 3 TCR CDR atomic contacts with peptide and MHC (percentage of contacts).
From: Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen
α chain | β chain | ||||||||
|---|---|---|---|---|---|---|---|---|---|
CDR1 | CDR2 | HV4 | CDR3 | CDR1 | CDR2 | HV4 | CDR3 | ||
12-6 | Peptide | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 95 |
MHC | 5 | 42 | 0 | 30 | 5 | 3 | 0 | 13 | |
38-10 | Peptide | 15 | 0 | 0 | 66 | 13 | 1 | 0 | 5 |
MHC | 21 | 16 | 0 | 37 | 13 | 5 | 0 | 8 | |
1a2 | Peptide | 18 | 0 | 0 | 21 | 0 | 2 | 0 | 59 |
MHC | 22 | 30 | 0 | 47 | 0 | 0 | 0 | 2 | |
